111 related articles for article (PubMed ID: 30070937)
1. BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.
Wang F; Zhao S; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Xing M
J Clin Oncol; 2018 Sep; 36(27):2787-2795. PubMed ID: 30070937
[TBL] [Abstract][Full Text] [Related]
2. Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.
Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
J Clin Oncol; 2018 Feb; 36(5):438-445. PubMed ID: 29240540
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment.
Huang Y; Qu S; Zhu G; Wang F; Liu R; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
J Natl Cancer Inst; 2018 Apr; 110(4):362-370. PubMed ID: 29165667
[TBL] [Abstract][Full Text] [Related]
4. A six-genotype genetic prognostic model for papillary thyroid cancer.
Shen X; Liu R; Xing M
Endocr Relat Cancer; 2017 Jan; 24(1):41-52. PubMed ID: 27875244
[TBL] [Abstract][Full Text] [Related]
5. Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography.
Agyekum EA; Wang YG; Xu FJ; Akortia D; Ren YZ; Chambers KH; Wang X; Taupa JO; Qian XQ
Sci Rep; 2023 Aug; 13(1):12604. PubMed ID: 37537230
[TBL] [Abstract][Full Text] [Related]
6. Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.
Liu R; Zhu G; Tan J; Shen X; Xing M
J Natl Cancer Inst; 2024 May; 116(5):694-701. PubMed ID: 38113409
[TBL] [Abstract][Full Text] [Related]
7. A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occult papillary thyroid carcinoma: A case report.
Chen L; Wu Y; Bai H; Liu H; Li X
Medicine (Baltimore); 2021 Feb; 100(6):e24458. PubMed ID: 33578538
[TBL] [Abstract][Full Text] [Related]
8. A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer.
Lin AJ; Samson P; DeWees T; Henke L; Baranski T; Schwarz J; Pfeifer J; Grigsby P; Markovina S
Cancer Med; 2019 Jan; 8(1):437-446. PubMed ID: 30552739
[TBL] [Abstract][Full Text] [Related]
9. The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.
Ricarte-Filho JC; Halada S; O'Neill A; Casado-Medrano V; Laetsch TW; Franco AT; Bauer AJ
Cancer Genet; 2022 Apr; 262-263():57-63. PubMed ID: 35092884
[TBL] [Abstract][Full Text] [Related]
10. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract][Full Text] [Related]
11. Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targets in Thyroid Cancer.
Zhang W; Lin S; Wang Z; Zhang W; Xing M
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38735658
[TBL] [Abstract][Full Text] [Related]
12. Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
Wu L; Vaccarella S; Feng CY; Dal Maso L; Chen Y; Liu WW; Liang MB; Zhang Z; Yang J; Cao SM; Li M
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855414
[TBL] [Abstract][Full Text] [Related]
13. CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.
Janjigian YY; Bendell J; Calvo E; Kim JW; Ascierto PA; Sharma P; Ott PA; Peltola K; Jaeger D; Evans J; de Braud F; Chau I; Harbison CT; Dorange C; Tschaika M; Le DT
J Clin Oncol; 2018 Oct; 36(28):2836-2844. PubMed ID: 30110194
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Lordick F; D'Journo XB; Cerfolio RJ; Korst RJ; Novoa NM; Swanson SJ; Brunelli A; Ismail M; Fernando HC; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J;
J Clin Oncol; 2018 Sep; 36(27):2796-2803. PubMed ID: 30089078
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.
Huang CL; Xu C; Zhang Y; Zhou GQ; Mao YP; Liu Q; Sun Y; Ma J; Tang LL
Radiat Oncol; 2018 Aug; 13(1):141. PubMed ID: 30081932
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
17.
Tan J; Liu R; Zhu G; Umbricht CB; Xing M
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15846-15851. PubMed ID: 32561648
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study.
Li X; Zhang S; Zhang Q; Wei X; Pan Y; Zhao J; Xin X; Qin C; Wang X; Li J; Yang F; Zhao Y; Yang M; Wang Q; Zheng Z; Zheng X; Yang X; Whitlow CT; Gurcan MN; Zhang L; Wang X; Pasche BC; Gao M; Zhang W; Chen K
Lancet Oncol; 2019 Feb; 20(2):193-201. PubMed ID: 30583848
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
Samà MT; Grosso E; Mele C; Laurora S; Monzeglio O; Marzullo P; Boldorini R; Aluffi Valletti P; Aimaretti G; Scatolini M; Pagano L
Endocrine; 2021 Jan; 71(1):149-157. PubMed ID: 32621051
[TBL] [Abstract][Full Text] [Related]
20. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
